Des Moines, IA & Washington, DC – Today Opioid Clinical Management (OPCM) announced a strategic partnership with Hon. Jim Carroll, the former Director of the White House Office of National Drug Control Policy (more colloquially known as the United States “Drug Czar”) and Hon. Uttam Dhillon, the former Acting Administrator of the United States Drug Enforcement Administration (DEA). The alliance will allow OPCM to intensify its government relations advocacy and promotion of its Opioid RX product suite.
“I am pleased to welcome Mr. Carroll and Mr. Dhillon to the Opioid Clinical Management team,” OPCM founder and CEO Mike Vasquez stated. “Their strong bipartisan relationships, extensive federal experience, and the broad respect they enjoy among key policymakers in Washington will bolster OPCM at this critical time.”
Opioid Clinical Management, Inc (“OPCM”) is a unique technology company that provides opioid prescription risk/case management for large, self-insured employers through its Opioid Prescription (ORx) Suite©. Unique software algorithms combined with artificial intelligence technology (ORx Risk Profiler©) allows OPCM to confidentially identify providers that are not adhering to best practice for a company’s employees. The majority of network providers are not trained in pain management and painkiller prescribing, resulting in painkillers not being discontinued when the therapeutic benefit of opioids has been reached.
“OPCM provides unique products to answer a definite need: helping self-insured employers attack costs and overprescribing by providers,” Carroll said. “I look forward to making more business leaders, elected officials, and law enforcement aware of their crucial work.”
“Ending the opioid epidemic requires tackling the problem in innovative ways, and OPCM does exactly that,” Dhillon said. “I welcome this opportunity to increase awareness and use of OPCM products, decreasing employer liability and saving lives — it’s a win-win.”
About Hon. Jim Carroll:
Jim Carroll most recently served as the United States “Drug Czar” for three years, unanimously confirmed to the position by the United States Senate. He oversaw an annual budget of $35 billion, successfully coordinating and monitoring the activities of 16 Federal Government agency budgets and funding. Under his leadership, overdose deaths declined for the first time 29 years, federal grants supporting public health programs reached their highest levels, and drug interdictions stood at all-time highs. Prior to ONDCP, Mr. Carroll served as White House Deputy Chief of Staff and General Counsel for the Office of Management and Budget. He previously served as Washington Counsel, Global Director of Compliance for Ford Motor Company. During the George W. Bush Administration, he served as Special Assistant and Associate Counsel to the President, Deputy General Counsel and Acting General Counsel at the U.S. Department of Treasury, and as an attorney at the U.S. Department of Justice.
About Hon. Uttam Dhillon:
Mr. Dhillon served as the fifteenth director of INTERPOL Washington — the U.S. National Central Bureau (USNCB) — until January 2021. As Director, Mr. Dhillon acted as the official U.S. representative to the International Criminal Police Organization (INTERPOL), the world’s largest police organization, and its 194 member countries. From 2018 to 2020, Mr. Dhillon served as the Acting Administrator of the Drug Enforcement Administration where he led a workforce of over 15,000 and oversaw a budget of $3.2 billion. Mr. Dhillon was responsible for DEA’s enforcement, intelligence, administration and regulatory activities worldwide. Mr. Dhillon has also served as Deputy Counsel and Deputy Assistant to the President, as an Associate Deputy Attorney General, and as a federal prosecutor. In 2006, Mr. Dhillon was unanimously confirmed by the United States Senate as the first Director of the Office of Counternarcotics Enforcement at the Department of Homeland Security. Mr. Dhillon has significant Congressional experience including serving as Chief Oversight Counsel for the House Financial Services Committee, Chief Counsel and Deputy Staff Director for the House Select Committee on Homeland Security, and Senior Investigative Counsel for the House Committee on Government Reform and Oversight.
Opioid Clinical Management Inc. (OPCM) is an organization dedicated to dealing with the national opioid crisis by addressing and correcting overprescribing. Using patent-pending predictive analytics, along with company healthcare data, OPCM’s OpioidRx service identifies patterns of opioid dependency within an organization’s health care network. Rather than identify individual employees, OPCM identifies physicians who are overprescribing opioids and confidentially intervenes on a company’s behalf, working with physicians and healthcare providers to adopt CDC best practices for prescribing opioids.
Visit www.opioidcm.com for more information.
Video Link: http://player.vimeo.com/video/325679267